Cargando…

Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody

Autoimmune pulmonary alveolar proteinosis (APAP) is caused by macrophage dysfunction due to anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody. We experienced 2 cases of APAP complicated with sarcoidosis in a 42-year-old woman and a 51-year-old man (age at the sarcoidosis di...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Toru, Kasai, Takahiko, Shimizu, Kazunori, Kawahara, Kunimitsu, Katayama, Kanako, Sugimoto, Chikatoshi, Hirose, Masaki, Okamoto, Hiroyuki, Tachibana, Kazunobu, Akira, Masanori, Inoue, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662056/
https://www.ncbi.nlm.nih.gov/pubmed/32611952
http://dx.doi.org/10.2169/internalmedicine.3853-19
_version_ 1783609319805157376
author Arai, Toru
Kasai, Takahiko
Shimizu, Kazunori
Kawahara, Kunimitsu
Katayama, Kanako
Sugimoto, Chikatoshi
Hirose, Masaki
Okamoto, Hiroyuki
Tachibana, Kazunobu
Akira, Masanori
Inoue, Yoshikazu
author_facet Arai, Toru
Kasai, Takahiko
Shimizu, Kazunori
Kawahara, Kunimitsu
Katayama, Kanako
Sugimoto, Chikatoshi
Hirose, Masaki
Okamoto, Hiroyuki
Tachibana, Kazunobu
Akira, Masanori
Inoue, Yoshikazu
author_sort Arai, Toru
collection PubMed
description Autoimmune pulmonary alveolar proteinosis (APAP) is caused by macrophage dysfunction due to anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody. We experienced 2 cases of APAP complicated with sarcoidosis in a 42-year-old woman and a 51-year-old man (age at the sarcoidosis diagnosis). APAP preceded sarcoidosis in the woman, and both diseases were diagnosed simultaneously in the man. Sarcoidosis lesions were observed in the lung, skin, and eyes, and the pathological findings of APAP were not marked at the diagnosis of sarcoidosis in either case. Low-grade positive serum anti-GM-CSF autoantibody was suspected to be correlated with the occurrence of sarcoidosis and resolution of APAP.
format Online
Article
Text
id pubmed-7662056
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-76620562020-11-25 Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody Arai, Toru Kasai, Takahiko Shimizu, Kazunori Kawahara, Kunimitsu Katayama, Kanako Sugimoto, Chikatoshi Hirose, Masaki Okamoto, Hiroyuki Tachibana, Kazunobu Akira, Masanori Inoue, Yoshikazu Intern Med Case Report Autoimmune pulmonary alveolar proteinosis (APAP) is caused by macrophage dysfunction due to anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody. We experienced 2 cases of APAP complicated with sarcoidosis in a 42-year-old woman and a 51-year-old man (age at the sarcoidosis diagnosis). APAP preceded sarcoidosis in the woman, and both diseases were diagnosed simultaneously in the man. Sarcoidosis lesions were observed in the lung, skin, and eyes, and the pathological findings of APAP were not marked at the diagnosis of sarcoidosis in either case. Low-grade positive serum anti-GM-CSF autoantibody was suspected to be correlated with the occurrence of sarcoidosis and resolution of APAP. The Japanese Society of Internal Medicine 2020-06-30 2020-10-15 /pmc/articles/PMC7662056/ /pubmed/32611952 http://dx.doi.org/10.2169/internalmedicine.3853-19 Text en Copyright © 2020 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Arai, Toru
Kasai, Takahiko
Shimizu, Kazunori
Kawahara, Kunimitsu
Katayama, Kanako
Sugimoto, Chikatoshi
Hirose, Masaki
Okamoto, Hiroyuki
Tachibana, Kazunobu
Akira, Masanori
Inoue, Yoshikazu
Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody
title Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody
title_full Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody
title_fullStr Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody
title_full_unstemmed Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody
title_short Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody
title_sort autoimmune pulmonary alveolar proteinosis complicated with sarcoidosis: the clinical course and serum levels of anti-granulocyte-macrophage colony-stimulating factor autoantibody
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662056/
https://www.ncbi.nlm.nih.gov/pubmed/32611952
http://dx.doi.org/10.2169/internalmedicine.3853-19
work_keys_str_mv AT araitoru autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody
AT kasaitakahiko autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody
AT shimizukazunori autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody
AT kawaharakunimitsu autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody
AT katayamakanako autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody
AT sugimotochikatoshi autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody
AT hirosemasaki autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody
AT okamotohiroyuki autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody
AT tachibanakazunobu autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody
AT akiramasanori autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody
AT inoueyoshikazu autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody